The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death

被引:459
作者
Basu, A [1 ]
Haldar, S [1 ]
机构
[1] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Pharmacol, Ireland Canc Ctr,Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA
关键词
apoptosis; Bax; Bcl2; cell cycle; p53;
D O I
10.1093/molehr/4.12.1099
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Each cell is under constant surveillance to maintain the integrity of its genome. Genomic lesions in a cell must be repaired before the onset of DNA replication and cell division. In the scenario that the genomic lesion is not repairable, the damaged cells are disposed in an orderly manner known as programmed cell death or apoptosis. Apoptosis and cell cycle progression are two intimately linked phenomena. Uncontrollable cell proliferation perturbs the cellular homeostasis and this can lead to malignancies, as well as organ dysfunction and developmental abnormalities. The biological pathway controlling cell fate is sequentially organized at the molecular level. Recent studies have made important contributions in advancing our knowledge of the mechanisms of cell cycle control and apoptosis regulation. A oncogene-derived protein, Bcl2, confers negative control in the pathway of cellular suicide machinery. A Bcl2-homologous protein, Bax, promotes cell death by competing with Bcl2. While Bax-Bax homodimers act as apoptosis inducers, Bcl2-Bax heterodimer formation evokes a survival signal for the cells. Both Bcl2 and Bax are transcriptional targets for the tumour suppressor protein, p53, which induces cell cycle arrest or apoptosis in response to DNA damage. In all, the coordinate performance of these molecules is crucial for controlling life and death of a cell.
引用
收藏
页码:1099 / 1109
页数:11
相关论文
共 127 条
[1]   Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors [J].
Armstrong, RC ;
Aja, T ;
Xiang, JL ;
Gaur, S ;
Krebs, JF ;
Hoang, K ;
Bai, X ;
Korsmeyer, J ;
Karanewsky, DS ;
Fritz, LC ;
Tomaselli, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16850-16855
[2]  
BAFFY G, 1993, J BIOL CHEM, V268, P6511
[3]  
Basu A., 1996, EOS-Rivista di Immunologia ed Immunofarmacologia, V16, P41
[4]  
Blagosklonny MV, 1997, CANCER RES, V57, P130
[5]  
Blagosklonny MV, 1996, CANCER RES, V56, P1851
[6]   THE PROTEIN PHOSPHATASE INHIBITOR OKADAIC ACID INDUCES MORPHOLOGICAL-CHANGES TYPICAL OF APOPTOSIS IN MAMMALIAN-CELLS [J].
BOE, R ;
GJERTSEN, BT ;
VINTERMYR, OK ;
HOUGE, G ;
LANOTTE, M ;
DOSKELAND, SO .
EXPERIMENTAL CELL RESEARCH, 1991, 195 (01) :237-246
[7]  
Boersma AWM, 1997, CYTOMETRY, V27, P275, DOI 10.1002/(SICI)1097-0320(19970301)27:3<275::AID-CYTO10>3.0.CO
[8]  
2-Q
[9]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[10]   THE PROTEIN BCL-2-ALPHA DOES NOT REQUIRE MEMBRANE ATTACHMENT, BUT 2 CONSERVED DOMAINS TO SUPPRESS APOPTOSIS [J].
BORNER, C ;
MARTINOU, I ;
MATTMANN, C ;
IRMLER, M ;
SCHAERER, E ;
MARTINOU, JC ;
TSCHOPP, J .
JOURNAL OF CELL BIOLOGY, 1994, 126 (04) :1059-1068